BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34890019)

  • 1. HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups.
    Nomah DK; Reyes-Urueña J; Llibre JM; Ambrosioni J; Ganem FS; Miró JM; Casabona J
    Curr HIV/AIDS Rep; 2021 Dec; 18(6):518-526. PubMed ID: 34890019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups.
    Nomah DK; Reyes-Urueña J; Llibre JM; Ambrosioni J; Ganem FS; Miró JM; Casabona J
    Curr HIV/AIDS Rep; 2022 Feb; 19(1):17-25. PubMed ID: 35113346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Outcomes and Risk Factors Among People Living with HIV.
    Spinelli MA; Jones BLH; Gandhi M
    Curr HIV/AIDS Rep; 2022 Oct; 19(5):425-432. PubMed ID: 35930187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Interrelationship between HIV Infection and COVID-19: A Review of the Literature.
    Wang Y; Lai Y
    Curr HIV Res; 2024; 22(1):6-15. PubMed ID: 38151836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States.
    Byrd KM; Beckwith CG; Garland JM; Johnson JE; Aung S; Cu-Uvin S; Farmakiotis D; Flanigan T; Gillani FS; Macias-Gil R; Mileno M; Ramratnam B; Rybak NR; Sanchez M; Tashima K; Mylonakis E; Kantor R
    J Int AIDS Soc; 2020 Jul; 23(7):e25573. PubMed ID: 32657527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological, Virological and Serological Features of Coronavirus Disease 2019 (COVID-19) Cases in People Living With Human Immunodeficiency Virus in Wuhan: A Population-based Cohort Study.
    Huang J; Xie N; Hu X; Yan H; Ding J; Liu P; Ma H; Ruan L; Li G; He N; Wei S; Wang X
    Clin Infect Dis; 2021 Oct; 73(7):e2086-e2094. PubMed ID: 32803216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressing Questions and Challenges in the HIV-1 and SARS-CoV-2 Syndemic.
    Montano M
    AIDS Res Hum Retroviruses; 2021 Aug; 37(8):589-600. PubMed ID: 33587013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection with HIV: clinical case series analysis in North Central Nigeria.
    Akyala AI; Iwu CJ
    Pan Afr Med J; 2020; 37():47. PubMed ID: 33209174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes and immunological response to SARS-CoV-2 infection among people living with HIV.
    Amegashie EA; Asamoah P; Ativi LEA; Adusei-Poku M; Bonney EY; Tagoe EA; Paintsil E; Torpey K; Quaye O
    Exp Biol Med (Maywood); 2024; 249():10059. PubMed ID: 38628843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher intensive care unit consultations for COVID-19 patients living with HIV compared to those without HIV coinfection in Uganda.
    Fleischer B; Olum R; Nakwagala FN; Nassozi DR; Pitua I; Paintsil E; Baluku JB; Bongomin F
    J Med Virol; 2022 Sep; 94(9):4294-4300. PubMed ID: 35620807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of platelet-and endothelial-associated biomarkers of disease activity in people hospitalized with Covid-19 with and without HIV co-infection.
    van der Mescht MA; Steel HC; de Beer Z; Abdullah F; Ueckermann V; Anderson R; Rossouw TM
    Front Immunol; 2023; 14():1235914. PubMed ID: 37646024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: the MACS/WIHS combined cohort study.
    D'Souza G; Springer G; Gustafson D; Kassaye S; Alcaide ML; Ramirez C; Sharma A; Palella FJ; Tien PC; Detels R; Kempf MC; Lahiri CD; Rinaldo CR; French AL; Margolick JB; Adimora AA
    HIV Res Clin Pract; 2020 Oct; 21(5):130-139. PubMed ID: 33211636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications.
    Dutta D; Liu J; Xiong H
    Viruses; 2023 May; 15(5):. PubMed ID: 37243203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review and Meta-Analyses of The Interaction Between HIV Infection And COVID-19: Two Years' Evidence Summary.
    Wang Y; Xie Y; Hu S; Ai W; Tao Y; Tang H; Jing F; Tang W
    Front Immunol; 2022; 13():864838. PubMed ID: 35619709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of SARS-CoV-2 Infection Among People Living With HIV in Wuhan, China.
    Wu M; Ming F; Wu S; Liu Y; Zhang X; Guo W; Marley G; Tang W; Liang K
    Front Public Health; 2022; 10():833783. PubMed ID: 35570882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 and HIV: Epidemiology, Treatment, and Lessons Learned from HIV.
    Castel AD; Wilbourn B; Magnus M; Greenberg AE
    AIDS Rev; 2020; 22(3):133-142. PubMed ID: 33118529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines.
    Yang Y; Iwasaki A
    Curr HIV/AIDS Rep; 2022 Feb; 19(1):5-16. PubMed ID: 34843064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?
    Augello M; Bono V; Rovito R; Tincati C; Marchetti G
    Curr HIV/AIDS Rep; 2023 Apr; 20(2):51-75. PubMed ID: 36680700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and
    González-Domenech CM; Pérez-Hernández I; Gómez-Ayerbe C; Viciana Ramos I; Palacios-Muñoz R; Santos J
    Viruses; 2021 May; 13(5):. PubMed ID: 34067925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 infection in people living with HIV.
    Brolly J; Chadwick DR
    Br Med Bull; 2023 Sep; 147(1):20-30. PubMed ID: 37312594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.